Staying abreast of the changing landscape of caries risk assessment, management, and prevention will help oral health professionals provide the highest quality patient care.
In order to safely and effectively manage this patient population, oral health professionals should be able to recognize the medical indications for which antiplatelets are prescribed and understand their adverse effects.
The United States Food and Drug Administration (FDA) has granted "Breakthrough Therapy Designation" to silver diamine fluoride (SDF) (38%) for the arrest of dental caries.